Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Jasper Therapeutics, Inc. | Executive Vice President, Research and Development | Stock Option (right to buy) | 7.5K | Mar 21, 2022 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
JSPR | Jasper Therapeutics, Inc. | Mar 21, 2022 | 1 | $0 | 4 | Mar 23, 2022 | Executive Vice President, Research and Development |
JSPR | Jasper Therapeutics, Inc. | Sep 24, 2021 | 0 | $0 | 3 | Oct 1, 2021 | EVP, Research and Development |